Patents by Inventor Yasunori Takada
Yasunori Takada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130144226Abstract: A medical adhesive patch includes: a support film including a barrier layer which contains polyvinyl alcohol and a layered inorganic compound, and which is laminated on one surface of a support including polyurethane; an adhesive layer which contains a medicine, and which is laminated on the barrier layer of the support film, a degree of saponification of the polyvinyl alcohol is equal to or more than 70% and equal to or less than 95.5%.Type: ApplicationFiled: June 15, 2011Publication date: June 6, 2013Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Yasunori Takada, Takito Shima, Tetsurou Tateishi, Tsuguki Nishihara, Chiaki Yoshida, Atsushi Matsushima, Tsuyoshi Takamiya
-
Publication number: 20130053358Abstract: Provided is a transdermal preparation having low skin irritation as well as a sufficient skin permeability rate of donepezil, which comprises one or more drugs selected from donepezil and pharmaceutically acceptable salts thereof. Also provided are a manufacturing method thereof, and a method for reducing skin irritation of a transdermally absorbable donepezil-containing preparation. An embodiment is a transdermal preparation comprising one or more drugs selected from donepezil and pharmaceutically acceptable salts thereof, and a skin irritation-reducing agent.Type: ApplicationFiled: April 27, 2011Publication date: February 28, 2013Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Kazunosuke Aida, Yasunari Michinaka, Kenji Atarashi, Yasunori Takada
-
Publication number: 20120171278Abstract: A transdermal patch comprising a backing 2 and an adhesive layer 3 laminated on the backing 2, wherein the adhesive layer 3 comprises a rosin-based resin and petroleum resin as a tackifier, the total compounding amount of the rosin-based resin and the petroleum resin is in a range of 15% by mass to 50% by mass, and compounding amount of the petroleum resin is 1/3 times by mass to 4 times by mass as that of the rosin-based resin.Type: ApplicationFiled: March 13, 2012Publication date: July 5, 2012Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Yasunori TAKADA, Koji TANAKA, Yasuhiro IKEURA
-
Publication number: 20120090275Abstract: The present invention relates to an adhesive patch-containing package bag 1, having: a package bag 8; and an adhesive patch 10 stored inside the package bag 8, wherein the adhesive patch 10 has a backing 12, an adhesive layer 14 laminated on at least one side of the backing 12 and containing ropinirole and/or a pharmaceutically acceptable salt thereof, and a release liner 16 covering the adhesive layer 14, and a relative humidity at 4° C. is maintained at 35% or higher inside the package bag 8.Type: ApplicationFiled: April 23, 2010Publication date: April 19, 2012Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Naoyuki Uchida, Yuka Takagi, Yasunori Takada
-
Patent number: 8158145Abstract: A transdermal patch comprising a backing 2 and an adhesive layer 3 laminated on the backing 2, wherein the adhesive layer 3 comprises a rosin-based resin and petroleum resin as a tackifier, the total compounding amount of the rosin-based resin and the petroleum resin is in a range of 15% by mass to 50% by mass, and compounding amount of the petroleum resin is ? times by mass to 4 times by mass as that of the rosin-based resin.Type: GrantFiled: February 19, 2003Date of Patent: April 17, 2012Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Publication number: 20120052113Abstract: The present invention relates to a transdermal preparation having a backing and an adhesive layer laminated on the backing, wherein the adhesive layer contains 4E indolone and a physiologically active compound.Type: ApplicationFiled: May 7, 2010Publication date: March 1, 2012Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Naoyuki Uchida, Yuka Takagi, Yasunori Takada
-
Publication number: 20120031047Abstract: A method for storing a transdermally/transmucosally absorbable preparation, comprising keeping a transdermally/transmucosally absorbable preparation enclosed in a container in a low oxygen atmosphere, the transdermally/transmucosally absorbable preparation comprising a drug whose molecule has an amino group substituted with a lower alkyl group.Type: ApplicationFiled: August 2, 2011Publication date: February 9, 2012Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Tomohiro SHINODA, Takashi Yasukouchi, Yasunori Takada
-
Patent number: 8034374Abstract: An adhesive patch containing a non-steroidal anti-inflammatory agent, comprising a support and an adhesive layer laminated on this support, wherein the adhesive layer contains a non-steroidal anti-inflammatory agent having a carboxyl group or its salt, and polyethylene glycol having an average molecular weight of 1000 or more.Type: GrantFiled: March 18, 2004Date of Patent: October 11, 2011Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Kiyomi Tsuruda
-
Patent number: 7615237Abstract: Percutaneously absorbable preparations (preferably nonaqueous ones, particularly matrix-type patches or ointment), containing salt-form acidic drugs and characterized by being improved in the percutaneous absorbability of the drug by the incorporation of an addition salt of a basic substance therewith and by being lowly irritant to the skin; and a percutaneous absorption accelerator for salt-form acidic drugs, containing an addition salt of a basic substance.Type: GrantFiled: July 11, 2000Date of Patent: November 10, 2009Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Publication number: 20070280980Abstract: A percutaneous pharmaceutical preparation for external use containing a nonsteroidal antiinflammatory analgesic. It is effective in inhibiting, with higher certainty, the hypersensitivity to light attributable to the phototoxicity and photoallergy of nonsteroidal antiinflammatory analgesics. It can sufficiently produce the effects of the nonsteroidal antiinflammatory analgesic while preventing the pharmaceutical preparation from being altered with time by the incorporation of a dibenzoylmethane derivative as a UVA absorber. The percutaneous pharmaceutical preparation for external use comprises, as essential ingredients, a nonsteroidal antiinflammatory analgesic, a dibenzoylmethane derivative, and one or more members selected among polyhydric alcohol/fatty acid esters, higher fatty acid esters, and crotamiton.Type: ApplicationFiled: May 13, 2005Publication date: December 6, 2007Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yoshiaki Hashimoto, Yasunori Takada, Miyuki Shinmura, Kiyomi Tsuruda
-
Publication number: 20070154531Abstract: An adhesive patch comprising a substrate and a pressure-sensitive adhesive base, wherein the pressure-sensitive adhesive base comprises a rubbery polymer having double bonds in the main chain and a nonsteroidal anti-inflammatory analgesic and contains a UVA screening agent and/or UVB screening agent as a stabilizer for the rubbery polymer. The adhesive patch is excellent in the stability of the pressure-sensitive adhesive base and in drug infiltration into the skin.Type: ApplicationFiled: December 24, 2004Publication date: July 5, 2007Inventors: Yoshiaki Hashimoto, Yasunori Takada, Miyuki Shinmura, Shigeo Suzuki, Kiyomi Tsuruda, Koichi Ikesue
-
Publication number: 20060198880Abstract: With the purpose of providing patches which do not cause photodecomposition of drugs even when exposed to the direct rays of the sun and which exhibit satisfactory drug effects and are excellent in physical properties and stability of pharmaceutical preparations, the invention provides a patch comprising a polyester substrate and a pressure-sensitive adhesive layer formed on one surface of the substrate and containing a nonsteroidal anti-inflammatory drug (NSAID) wherein the substrate contains a hydroxyphenylbenzotriazole derivative represented by the general formula (1): wherein R1 and R2 are each independently hydrogen or C1-8 alkyl; and X is halogen atom.Type: ApplicationFiled: May 7, 2004Publication date: September 7, 2006Applicant: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Yoshiaki Hashimoto, Yasunori Takada, Kiyomi Tsuruda
-
Publication number: 20060172002Abstract: An adhesive patch containing a non-steroidal anti-inflammatory agent, comprising a support and an adhesive layer laminated on this support, wherein the adhesive layer contains a non-steroidal anti-inflammatory agent having a carboxyl group or its salt, and polyethylene glycol having an average molecular weight of 1000 or more.Type: ApplicationFiled: March 18, 2004Publication date: August 3, 2006Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Kiyomi Tsuruda
-
Publication number: 20050129748Abstract: A transdermal patch comprising a backing 2 and an adhesive layer 3 laminated on the backing 2, wherein the adhesive layer 3 comprises a rosin-based resin and petroleum resin as a tackifier, the total compounding amount of the rosin-based resin and the petroleum resin is in a range of 15% by mass to 50% by mass, and compounding amount of the petroleum resin is ? times by mass to 4 times by mass as that of the rosin-based resin.Type: ApplicationFiled: February 19, 2003Publication date: June 16, 2005Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Patent number: 6844007Abstract: A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plaster does not contain crotamiton which is a solubilizer for the felbinac, the felbinac is uniformly dispersed in a semi-solubilized state in the plaster, wherein solubilized felbinac and microcrystalline felbinac coexist in the plaster, and a thickness of the plaster is 50-300 ?m.Type: GrantFiled: June 27, 2003Date of Patent: January 18, 2005Assignee: Hisamitsu Pharmaceutical Co., Ltd.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Patent number: 6833138Abstract: A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plaster does not contain crotamiton which is a solubilizer for the felbinac, the felbinac is uniformly dispersed in a semi-solubilized state in the plaster, wherein solubilized felbinac and microcrystalline felbinac coexist in the plaster, and a thickness of the plaster is 50-300 &mgr;m.Type: GrantFiled: June 27, 2003Date of Patent: December 21, 2004Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Publication number: 20040146548Abstract: It is intended to provide percutaneously absorbable patches having an improved percutaneous absorbability of an anti-inflammatory agent in the form of a salt and an improved stability. Namely, percutaneously absorbable patches having an adhesive base layer which contains an anti-inflammatory agent in the form of a salt, an ammonium salt compound, an absorption enhancer and/or a solubilizer.Type: ApplicationFiled: November 25, 2003Publication date: July 29, 2004Inventors: Yasunori Takada, Koji Tanaka, Tomonori Kurita, Yasuhiro Ikeura
-
Publication number: 20040086555Abstract: A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plaster does not contain crotamiton which is a solubilizer for the felbinac, the felbinac is uniformly dispersed in a semi-solubilized state in the plaster, wherein solubilized felbinac and microcrystalline felbinac coexist in the plaster, and a thickness of the plaster is 50-300 &mgr;m.Type: ApplicationFiled: June 27, 2003Publication date: May 6, 2004Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Publication number: 20040086554Abstract: A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plaster does not contain crotamiton which is a solubilizer for the felbinac, the felbinac is uniformly dispersed in a semi-solubilized state in the plaster, wherein solubilized felbinac and microcrystalline felbinac coexist in the plaster, and a thickness of the plaster is 50-300 &mgr;m.Type: ApplicationFiled: June 27, 2003Publication date: May 6, 2004Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura
-
Patent number: 6620430Abstract: A plaster comprising a styrene-isoprene-styrene block copolymer 10-40 wt %, a rosin-based resin 5-30 wt %, a plasticizer 20-70 wt %, polyisobutylene 6-40 wt %, an antioxidant 0.1-5 wt %, and felbinac as a medicinally effective component 1.1-10 wt %, wherein the plaster does not contain crotamiton which is a solubilizer for the felbinac, the felbinac is uniformly dispersed in a semi-solubilized state in the plaster, wherein solubilized felbinac and microcrystalline felbinac coexist in the plaster, and a thickness of the plaster is 50-300 &mgr;m.Type: GrantFiled: May 18, 2001Date of Patent: September 16, 2003Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Yasunori Takada, Koji Tanaka, Yasuhiro Ikeura